To protect our staff, community, and the UK National Health Service, Chemonics closed our London office on the 16th of March due to the ongoing COVID-19 pandemic. In the London area, the threat of human-to-human transmission remains high and the global community still lacks proven vaccines and therapeutics to effectively prevent and treat COVID-19.
Chemonics has conducted a comprehensive risk assessment and instituted robust mitigation measures for our London office that meet or exceed the UK Government’s guidance on managing COVID-19 in the workplace. With these measures in place our staff now have the option to work from our office, which reopened on the 10th of August.
Please see our certification of compliance with the Health and Safety Executive’s requirements here.